ABOUT USNCE PROJECTSNDDS PROJECTSTIMELINESINVESTORSPRESS
Active Projects in Drug Discovery/Delivery Systems, an expert scientific team and a clear approach to projects.


 

Allergy - SUN-1334H

  • Complete ongoing phase II human trials in the USA for season allergic rhinitis.
  • Complete studies on metabolism, toxicity etc required for phase III trials.
  • likely initiate phase III trials in 2008.

Inflammation - SUN-461

  • Complete the required preclinical and toxicity studies for Investigational New Drug (IND) application.
  • Obtain regulatory approval and commence phase I human studies.

Pro-drug - SUN-44

  • Complete the required preclinical and toxicity studies for Investigational New Drug (IND) application.
  • Obtain regulatory approval and commence phase I human studies.

Pro-drug - SUN-09

  • Complete the required preclinical and toxicity studies for Investigational New Drug (IND) applcation.
  • Obtain regulatory approval and likely commence phase I human studies.
   
Home
About Us
NCE Projects
NDDS Projects
Timelines
Investors
Press
Contact Us
Careers
Site Map
© Copyright Sun Pharma Advanced Research Company Ltd.